These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 25053104)

  • 61. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
    Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
    Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.
    Bosse KR; Shukla AR; Pawel B; Chikwava KR; Santi M; Tooke L; Castagna K; Biegel JA; Bagatell R
    Cancer Genet; 2014 Sep; 207(9):415-9. PubMed ID: 25018128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prenatal presentation of a metastasizing rhabdoid tumor with homozygous deletion of the SMARCB1 gene.
    Negahban S; Nagel I; Soleimanpour H; Aledavood A; Bagheri N; Paydar M; Daneshbod K; Hasselblatt M; Gesk S; Siebert R; Daneshbod Y
    J Clin Oncol; 2010 Nov; 28(33):e688-91. PubMed ID: 20805448
    [No Abstract]   [Full Text] [Related]  

  • 64. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.
    Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G
    Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
    Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
    Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
    Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
    [No Abstract]   [Full Text] [Related]  

  • 67. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
    Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
    Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.
    Savage N; Linn D; McDonough C; Donohoe JM; Franco A; Reuter V; Biddinger PW; Eaton KW; Biegel JA; Sharma S
    Ann Diagn Pathol; 2012 Dec; 16(6):504-7. PubMed ID: 21775180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Antonescu CR
    Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
    Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
    World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
    Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
    Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel mutation of the SMARCB1 gene in a case of extrarenal malignant rhabdoid tumor.
    Koitabashi M; Kanazawa T; Tamura K; Tsukada S; Suzuki M; Morikawa A; Ogawa C; Hirado J
    Cancer Genet Cytogenet; 2008 Feb; 181(1):67-8. PubMed ID: 18262058
    [No Abstract]   [Full Text] [Related]  

  • 75. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells.
    Vu-Han TL; Frühwald MC; Hasselblatt M; Kerl K; Nagel I; Obser T; Oyen F; Siebert R; Schneppenheim R
    Cancer Genet; 2014 Sep; 207(9):390-7. PubMed ID: 25016934
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
    Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
    Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.